Justin Stebbing: Amazing work to identify PANK4 as a major factor in resistance to routine treatment in one of the hardest-to-treat tumors, glioblastoma

Justin Stebbing shared on LinkedIn:

“Huge congratulations to an amazing team led by Georgios Giamas, for producing amazing work to identify PANK4 as being a major factor in resistance to routine treatment in one of the hardest-to-treat tumors, glioblastoma. Really lucky to be included here and the science is exceptional.”

Read further.
Source: Justin Stebbing/LinkedIn

Justin Stebbing is a visiting Professor of Cancer Medicine and Oncology at Imperial College, London, and a Professor of Biomedical Sciences at Anglia Ruskin University (ARU), Cambridge. He was appointed the first NIHR oncology professor in 2011. He is editor-in-chief of Nature’s cancer journal Oncogene.

Prof. Stebbing has published over 700 peer-reviewed papers in leading academic journals. He is a member of the American Society for Clinical Investigation, a fellow of the Royal College of Physicians, and the Royal College of Pathologists, and sits on many advisory boards. He is on the Editorial Board of OncoDaily.